4
Changes in Ownership
Werewolf Therapeutics, Inc. Filed Acc 0001231919-25-000459
10% owner sold 213,529 shares at an average $1.13 ($241,278)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| GADICKE ANSBERT 10% owner | 2025-11-07 | Sale 10b5-1 | −68,480 | $1.11 | $76,013 | 5,836,240 | I |
| GADICKE ANSBERT 10% owner | 2025-11-10 | Sale 10b5-1 | −48,570 | $1.18 | $57,313 | 5,787,670 | I |
| GADICKE ANSBERT 10% owner | 2025-11-11 | Sale 10b5-1 | −55,810 | $1.14 | $63,623 | 5,731,860 | I |
| GADICKE ANSBERT 10% owner | 2025-11-12 | Sale 10b5-1 | −40,669 | $1.09 | $44,329 | 5,691,191 | I |
| Open-market sales · 213,529 sh · avg $1.13 · $241,278 | |||||||
Loading xslF345X05/form4-11132025_121146.xml…